按动物类型、产品、治疗用途、分销管道和最终用户分類的动物保健市场 - 2025-2032 年全球预测

预计到 2032 年，动物保健市场将成长至 1,763 亿美元，复合年增长率为 8.67%。

主要市场统计数据
基准年2024年	906.2亿美元
预计2025年	985亿美元
预测年份：2032年	1763亿美元
复合年增长率（%）	8.67%

对不断发展的动物健康生态系统的简要介绍，重点关注重塑临床实践、供应链和相关人员之间合作的驱动因素

现代动物健康是公共卫生、食品安全和伴侣动物福利之间的关键连结。宠物数量的增加、畜牧业生产体系的集约化以及公众对通用感染疾病风险的日益认识，正在推动对强效预防和治疗解决方案的需求。同时，监管监督和管理工作正在重塑产品在不同物种和不同用途的开发、核准和部署方式。

人类和动物健康优先事项的融合正在推动兽医、生产者和公共卫生当局之间更紧密的合作，从而强化「同一个健康」框架。诊断、生技药品和数据分析领域的技术进步使得更早发现疾病、采取更有针对性的干预措施以及更好地监测治疗结果成为可能，而主导对永续性、透明度和减少抗菌药物使用的偏好正在影响产品开发路径和商业策略。

随着该行业逐渐摆脱传统模式，它强调透过多元化供应链、数位化服务交付以及跨部门研发伙伴关係来增强韧性。这些趋势迫使相关人员重新评估研究、製造、分销和现场服务方面的能力。随着新技术和政策变化的融合，领导者必须在当前临床需求与长期策略定位之间取得平衡，以保护动物健康和相关的人类健康目标。

重大的结构和技术变革正在重新定义整个动物保健产业的产品创新、临床实践和分销管道

该行业正处于一场变革性转变之中，这场转变正在重新定义临床实践、研究重点和商业模式。数位转型正在加速伴侣动物远端医疗平台和牲畜远端监控工具的普及，使临床医生和生产者能够做出更快、更准确、数据主导的决策。精准畜牧养殖技术，包括感测器和基因组分析工具，正在优化生产力和饲料效率，同时透过早期疗育降低疾病发病率。

在产品创新方面，生技药品和重组疫苗平台以及使分子检测更贴近临床的新一代诊断技术正日益受到关注。支持肠道健康和免疫力的饲料添加剂也日益受到关注，这反映出减少对传统抗生素依赖的广泛趋势。同时，法规和抗菌药物管理计划正在推动对替代疗法以及更严格的标籤和使用通讯协定的需求。

从商业性来看，供应商之间的整合以及药物开发商和技术提供者之间的策略联盟正在重塑竞争动态。不断发展的分销管道，包括线上销售和直接面向消费者的模式，正在改变饲主和兽医获取产品的方式。因此，那些兼具技术力、监管前瞻性和以客户为中心的分销模式的组织将在不同的物种和市场中获得差异化的价值。

评估美国关税政策的变化将如何再形成动物健康利益相关人员的供应链、采购决策和定价动态

预计2025年美国关税政策的调整将对动物保健产业产生复杂的影响，其影响远不止眼前的成本压力。关税变化往往会增加进口原材料和成品的到岸成本，这可能会挤压依赖国际供应链的製造商的净利率。为此，企业通常会重新评估筹资策略，转向较近的供应商或扩大国内产能，以降低贸易政策波动带来的风险。

这些调整也将影响疫苗成分、诊断剂和特种饲料添加剂等关键投入的物流和时间安排。通关时间和文件要求的增加可能会造成暂时的瓶颈，影响生技药品的低温运输连续性和对时间敏感的临床诊断产品的交付。因此，分销合作伙伴和兽医诊所可能会采取更保守的库存策略，增加营运资金需求，并需要更复杂的需求预测能力。

贸易政策的变化往往会引发市场重组，有些国家会将出口流从受关税影响的路线转移，而有些国家则会利用其竞争优势来填补供应缺口。企业应采取的积极措施包括重新设计采购合约以纳入关税转嫁条款、投资于关税分类专业知识，以及在区域枢纽寻求策略性库存缓衝。平衡成本回收与客户支付意愿的定价策略至关重要，与最终用户的透明沟通对于在成本调整期间维持信任至关重要。从中期来看，拥有多元化供应链、灵活製造和商业性敏捷性的企业可能最有能力吸收政策衝击，同时继续有效地服务兽医、生产商和饲主。

从全面的细分框架中获得洞察，该框架可识别物种、产品形态、治疗用途、分销管道和最终用户行为

细緻的细分框架揭示了临床需求、机会和营运复杂性在动物保健产品组合中的交汇点。按动物类型划分，市场涵盖伴侣动物和牲畜。伴侣动物细分市场主要关注犬和猫，其核心是预防保健、诊断和慢性疾病管理。而牲畜细分市场则包括水产养殖、牛、家禽和猪，每种动物都有特定的生物安全、疫苗接种和饲料管理重点，这些重点反映了它们的生产系统和疾病风险状况。

我们的产品包括诊断产品、饲料添加剂、抗寄生虫药、药品和疫苗。诊断产品分为免疫学方法和分子生物学方法，分别用于即时筛检和更深入的基因组分析。饲料添加剂包括酵素、益生元和益生菌，以促进最佳消化和恢復；抗寄生虫药物包括针对特定物种寄生虫量身定制的体外寄生虫药和体内寄生虫药物。药品分为品牌药和非专利药；疫苗包括灭活疫苗、减毒疫苗和重组疫苗，并采取不同的生产和监管途径。

依治疗用途细分，明确了感染疾病、抗发炎药、抗寄生虫药和荷尔蒙药物的临床定位。感染疾病进一步分为抗生素、抗真菌药物和抗病毒药，管理压力影响其使用。抗发炎药物分为皮质类固醇和非类固醇抗发炎药，反映了疗效和安全性之间的权衡。抗寄生虫药包括体外寄生虫药和体内寄生虫药，而荷尔蒙药物包括生长激素和生殖激素，主要用于生产。

分销通路细分揭示了影响覆盖范围和服务模式的市场路径变化。网路商店正在分化为直销网站和第三方平台，扩大了访问管道并提升了便利性。零售药局（包括连锁药局和独立药局）对宠物饲主仍然至关重要，而兽医诊所和诊所（从大型动物医院到小型动物诊所）在处方和治疗管理方面仍然发挥着重要作用。最终用户细分将动物主人、饲料製造商和兽医确定为关键决策者，其中动物主人包括畜牧养殖户和宠物主人，兽医分为大型动物、混合动物和小型动物执业兽医，每种类型都影响着产品的选择和采取路径。

影响全球动物保健市场产品采用、供应链设计和商业化策略的区域动态和法规环境

区域动态对整个动物保健市场的法规、供应链和采用率有重大影响。美洲地区呈现出多元化的特征，包括完善的法律规范、成熟的伴侣动物照护市场以及对生物安全有严格要求的大型商业畜牧养殖场。在该地区，私人兽医诊所和一体化生产系统推动了对诊断、疫苗和饲料优化解决方案的需求，而数位管道也日益成为传统分销网络的补充。

欧洲、中东和非洲 欧洲、中东和非洲呈现出多元化的格局，受许多欧洲市场严格的监管条件、日益普及的监管框架以及中东和非洲地区生产体系的差异性影响。该地区的需求优先考虑高品质的疫苗、诊断试剂和抗菌药物管理，以及针对小农户和商业生产者的客製化支援。各国基础设施的差异凸显了製定灵活配送和低温运输策略的必要性。

亚太地区的特点是生产系统快速现代化，水产养殖业活性化，伴侣动物照护市场不断发展。本地生产和研发投资不断成长，同时又依赖跨境贸易获取专业投入。监管改革、监管能力提升以及私营部门的大力参与，正在加速先进生技药品和分子诊断技术的推广应用。在各个地区，企业必须根据法规环境、通路结构以及兽医、生产商和饲主的不同需求，制定相应的商业性策略。

产业领导者采用的策略策略，重点在于创新、供应链弹性和现代化市场竞争，以保持竞争优势

该产业的主要企业正在采取策略态势，强调加强研发、产品组合多元化和通路创新。各公司正将资源配置到新型疫苗平台和分子诊断领域，同时拓展生技药品的能力，以解决饲料添加剂和抗菌药物管理的问题。药物开发商和技术供应商之间的策略合作伙伴关係将促进诊断驱动的治疗途径与数位医疗服务的快速整合。

在商业方面，企业正在透过向医疗保健提供者直销和数位销售管道相结合的方式优化分销。投资低温运输物流和本地製造能力可以降低供应中断和贸易政策变化带来的风险。同时，一些企业正在选择性地进行併购，以获取互补技术，增强其在高成长领域的影响力，并确保进入区域市场。

先进的品质系统、法规专业知识以及可扩展的製造外包关係有助于加快产品上市和生命週期管理。能够平衡创新与切合实际的供应链和商业化策略的公司更有可能保持竞争力。此外，透过培训、技术支援和性能数据共用与兽医和生产商持续合作，可以强化产品价值提案并推动产品采用。

为高阶主管提供高影响力的实用行动，以增强动物健康的復原力，加速数位化应用，并推动临床和商业性成果

动物保健产业的领导者应采取果断可行的措施，抓住机会，降低当前动态环境的风险。首先，优先考虑灵活的生产和供应商多元化，以减少受政策主导的中断和物流波动的影响。这包括检验关键投入的替代来源，投资本地生技药品填充能力，以及协商允许根据投入成本波动调整价格的合约。

其次，我们正在加速数位转型计划，以连接诊断和治疗途径，并为伴侣动物和牲畜提供远端医疗和远端倡议。将诊断数据与治疗通讯协定相结合，将改善临床结果，并支持与付款人和生产者进行基于价值的对话。第三，我们正在投资抗菌药物管理和替代治疗方案，并将这些努力与针对兽医和生产者的教育计画结合，以促进负责任的使用并满足监管要求。

第四，我们将根据地区和最终用户定製商业模式，将与兽医的直接互动、宠物饲主主人的数位化DTC体验以及与饲料製造商的策略伙伴关係相结合。最后，我们将把永续性和透明度融入我们的产品生命週期中。协同实施这些措施将增强韧性，加速产品采用，并在我们的产品组合中创造可衡量的价值。

一种透明、多方法的研究途径，结合了初步访谈、二次证据的整合和严格的三角测量来支持策略性发现

本研究结合定性和定量方法，提供严谨且可操作的分析。初步研究包括对兽医、生产经理、采购专业人员和行业专家的结构化访谈，以了解临床需求、采购驱动因素和分销挑战的实地观点。此外，我们也进行了二次研究，利用监管文件、科学文献、专利申请和上市公司资讯揭露，揭示技术发展轨迹和竞争定位。

数据三角测量技术检验了不同来源的洞察，并确保了实地回馈与记录趋势之间的一致性。細項分析运用物种、产品形态、治疗用途、分销管道和最终用户的视角，突显差异化的机会和限制因素。区域评估将政策审查与物流和基础设施分析相结合，以揭示各区域如何影响采用和供应链设计。

透过反覆的假设检验、同侪审查和情境分析，对贸易政策影响和技术采用的假设进行压力测试，以保持分析的严谨性。限制包括不同司法管辖区的监管时间表存在差异，以及某些区域的数据品质参差不齐。这些问题的解决方式是：使假设透明化，并在二手资料稀缺的情况下优先考虑关键相关人员的意见。出于道德方面的考虑，确保了所有受访者的保密性和自愿参与。

简洁的产业动态综合，强调创新、监管和营运弹性之间的相互作用，这将推动未来的动物健康策略

总而言之，在技术创新、法规演变和商业模式转变的推动下，动物保健产业正经历一场根本性的重构。诊断和疫苗平台的发展、数位医疗和精准畜牧业的兴起，以及对抗菌药物管理的日益重视，正在全面重塑产品开发和服务交付。同时，供应链的韧性和区域策略对于保障基本治疗和预防药物的可近性至关重要。

业界参与者若能将研发重点与管理目标结合，投资于灵活的生产和本地分销，并部署以客户为中心的数位化服务，将更有利于获取长期价值。同样重要的是，积极主动地与监管机构和兽医界沟通，确保新治疗方法在临床上可接受并符合法规要求。将切实可行的营运措施与创新策略投资结合，将使企业能够安然度过短期政策动盪，同时打造可持续的竞争优势。

展望未来，公共和私营部门之间的持续合作以及基于证据的商业化和负责任的使用实践对于改善动物健康结果、保护公众健康和支持永续的粮食系统至关重要。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 整合精准畜牧技术，实现大规模酪农养殖的即时健康监测
• 加速采用 mRNA 疫苗平台，以应对兽医学中新出现的通用感染疾病
• 实施人工智慧驱动的决策支援系统，优化伴侣动物治疗通讯协定
• 扩大畜牧生产中的抗菌药物管理项目，以应对日益严重的抗生素抗药性
• 增加微生物组调节疗法的投资，以取代传统的家禽生长促进剂
• 远端医疗和远距离诊断在农村兽医实践和畜群管理中的进展
• 基于区块链的供应链追踪解决方案的出现，确保动物产品来源的透明度
• 监管协调努力简化创新生技药品的全球核准流程
• 人们对气候适应性营养策略的兴趣日益浓厚，以提高动物对环境压力的适应能力
• 开发用于牲畜预防和治疗的物种特异性单株抗体疗法

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：动物保健市场（按动物类型）

• 伴侣动物
  • 猫
  • 狗
• 家畜
  • 水产养殖
  • 牛
  • 家禽
  • 猪

第九章动物保健产品市场

• 诊断
  • 免疫学诊断
  • 分子诊断
• 饲料添加剂
  • 酵素
  • 益生元
  • 益生菌
• 杀寄生虫剂
  • 杀外寄生虫剂
  • 体内杀寄生虫剂
• 製药
  • 品牌
  • 学名药
• 疫苗
  • 灭活疫苗
  • 活病毒疫苗
  • 重组

第 10 章：依治疗用途分類的动物保健市场

• 抗感染药物
  • 抗生素
  • 抗真菌药物
  • 抗病毒药物
• 抗发炎药物
  • 皮质类固醇
  • NSAIDs
• 抗寄生虫药
  • 杀外寄生虫剂
  • 体内杀寄生虫剂
• 荷尔蒙治疗药物
  • 生长激素
  • 生殖荷尔蒙

第 11 章动物保健市场（依分销管道）

• 网路商店
  • 消费者网站
  • 第三方平台
• 零售药局
  • 连锁药局
  • 独立药房
• 兽医医院和诊所
  • 大型动物医院
  • 小动物诊所

第 12 章动物保健市场（按最终用户）

• 动物饲主
  • 畜牧养殖户
  • 宠物饲主
• 饲料生产商
• 兽医
  • 大型动物兽医
  • 混合执业兽医
  • 小动物兽医

第十三章动物保健市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章动物保健市场（按类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第 15 章。按国家/地区分類的动物保健市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • IDEXX Laboratories, Inc.
  • Ceva Sante Animale SA
  • Vetoquinol SA
  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation

The Animal Health Market is projected to grow by USD 176.30 billion at a CAGR of 8.67% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 90.62 billion
Estimated Year [2025]	USD 98.50 billion
Forecast Year [2032]	USD 176.30 billion
CAGR (%)	8.67%

A concise orientation to the evolving animal health ecosystem highlighting drivers that reshape clinical practice, supply chains, and stakeholder collaborations

The contemporary animal health landscape occupies a critical nexus between public health, food security, and companion animal welfare. Rising pet ownership, intensifying livestock production systems, and heightened public awareness of zoonotic risks have elevated demand for robust preventive and therapeutic solutions. At the same time, regulatory scrutiny and stewardship initiatives are reshaping how products are developed, approved, and deployed across species and use cases.

Integration of human and animal health priorities has prompted closer collaboration among veterinarians, producers, and public health authorities, strengthening the One Health framework. Technological advances in diagnostics, biologics, and data analytics are enabling earlier detection of disease, more precise interventions, and improved monitoring of treatment outcomes. Meanwhile, consumer-driven preferences for sustainability, transparency, and reduced antimicrobial use are influencing product development pathways and commercial strategies.

Transitioning from traditional models, the sector now emphasizes resilience: diversified supply chains, digital-enabled service delivery, and cross-disciplinary R&D partnerships. These trends require stakeholders to reassess capabilities across research, manufacturing, distribution, and field services. As emerging technologies and policy shifts converge, leaders must balance immediate clinical needs with long-term strategic positioning to safeguard animal health and related human health objectives.

Major structural and technological shifts are redefining product innovation, clinical practice, and distribution channels across the animal health industry

The industry is in the midst of transformative shifts that are redefining clinical practice, research priorities, and commercial models. Digital transformation is accelerating adoption of telemedicine platforms for companion animals and remote monitoring tools for livestock, enabling clinicians and producers to make data-driven decisions with greater speed and precision. Precision livestock farming technologies, including sensors and genomic tools, are reducing disease incidence through earlier intervention while optimizing productivity and feed efficiency.

In product innovation, biologics and recombinant vaccine platforms are gaining traction alongside next-generation diagnostics that bring molecular testing closer to point-of-care settings. There is also a clear pivot toward feed additives that support gut health and immunity, reflecting a broader move to reduce reliance on traditional antibiotics. Concurrently, regulatory and antimicrobial stewardship programs are increasing demand for alternative therapies and tightened labeling and usage protocols.

Commercially, consolidation among suppliers and strategic partnerships between pharmaceutical developers and technology providers are reshaping competitive dynamics. Evolving distribution channels, notably online sales and direct-to-consumer models, are changing how owners and veterinarians access products. As a result, organizations that integrate technological capability, regulatory foresight, and customer-centric distribution will capture differentiated value across species and markets.

Assessing how shifts in United States tariff policy could reshape supply chains, procurement decisions, and pricing dynamics for animal health stakeholders

Anticipated adjustments to United States tariff policy in 2025 present a complex set of implications for the animal health sector that extend beyond immediate cost pressures. Tariff changes tend to increase the landed cost of imported raw materials and finished products, which can compress margins for manufacturers reliant on international supply chains. In response, firms often reassess sourcing strategies, shifting toward nearer-shore suppliers or expanding domestic manufacturing capacity to mitigate exposure to trade policy volatility.

These adjustments also influence the logistics and timing of critical inputs such as vaccine components, diagnostic reagents, and specialized feed additives. Heightened customs clearance times and documentation requirements can create temporary bottlenecks that affect cold-chain continuity for biologics and time-sensitive deliveries for clinical diagnostics. As a consequence, distribution partners and veterinary clinics may adopt more conservative inventory practices, which can increase working capital needs and require more sophisticated demand forecasting capabilities.

Trade policy shifts frequently catalyze market realignment, with some countries diverting export flows away from tariff-affected routes and others capitalizing on competitive advantages to fill supply gaps. For companies, proactive measures include redesigning procurement contracts to include tariff pass-through clauses, investing in tariff classification expertise, and pursuing strategic inventory buffers at regional hubs. Importantly, pricing strategies must balance cost recovery with customer willingness to pay, and transparent communication with end users is essential to maintain trust during periods of cost adjustment. Over the medium term, firms that combine supply chain diversification, flexible manufacturing, and commercial agility will be best positioned to absorb policy-driven shocks while continuing to serve veterinarians, producers, and pet owners effectively.

Insights derived from a comprehensive segmentation framework that clarifies species, product modalities, therapeutic uses, distribution channels, and end-user behaviors

A nuanced segmentation framework reveals where clinical need, commercial opportunity, and operational complexity intersect across animal health portfolios. When viewed by animal type, the market spans companion animals and livestock; the companion animal segment concentrates on cats and dogs where preventive care, diagnostics, and chronic disease management dominate, while the livestock segment includes aquaculture, cattle, poultry, and swine, each with specific biosecurity, vaccination, and feed management priorities that reflect production systems and disease risk profiles.

Product-focused segmentation distinguishes diagnostics, feed additives, parasiticides, pharmaceuticals, and vaccines. Diagnostics bifurcate into immunological and molecular methods, enabling point-of-care screening and deeper genomic insights respectively. Feed additives encompass enzymes, prebiotics, and probiotics aimed at optimizing digestion and resilience, whereas parasiticides include ectoparasiticides and endoparasiticides tailored to species-specific parasite burdens. Pharmaceuticals split into branded and generic offerings, while vaccines cover killed inactivated, live attenuated, and recombinant formats with divergent manufacturing and regulatory pathways.

Therapeutic application segmentation clarifies clinical positioning across anti-infectives, anti-inflammatories, antiparasitics, and hormonal therapeutics. Anti-infectives further differentiate into antibiotics, antifungals, and antivirals, with stewardship pressures influencing use profiles. Anti-inflammatories are divided into corticosteroids and NSAIDs, reflecting efficacy and safety trade-offs. Antiparasitics include both ecto- and endoparasiticides, and hormonal therapeutics encompass growth and reproductive hormones used primarily in production settings.

Distribution channel segmentation exposes the shifting routes to market that affect reach and service models. Online stores, split between direct-to-consumer websites and third-party platforms, are expanding access and convenience; retail pharmacies, including chain and independent outlets, remain important for pet owners; and veterinary hospitals and clinics, ranging from large animal hospitals to small animal clinics, continue to be pivotal for prescribing and administering treatments. End-user segmentation identifies animal owners, feed manufacturers, and veterinarians as primary decision-makers, with animal owners comprising livestock farmers and pet owners, and veterinarians categorized into large animal, mixed practice, and small animal practitioners, each influencing product selection and adoption pathways.

Regional dynamics and regulatory environments that shape product adoption, supply chain design, and commercialization strategies across global animal health markets

Regional dynamics exert a strong influence on regulation, supply chains, and adoption rates across animal health markets. The Americas region presents a diverse profile: established regulatory frameworks, mature companion animal care markets, and large-scale commercial livestock operations with intensive biosecurity needs. In this geography, private veterinary practice and integrated production systems drive demand for diagnostics, vaccines, and feed optimization solutions, while digital channels increasingly supplement traditional distribution networks.

Europe, Middle East & Africa exhibits a multifaceted landscape shaped by stringent regulatory standards in many European markets, rising adoption of stewardship frameworks, and heterogeneity across Middle Eastern and African production systems. Demand in this region tends to prioritize high-quality vaccines and diagnostics, antimicrobial stewardship, and tailored support for smallholder and commercial producers. Infrastructure variability across countries underscores the need for adaptable distribution and cold-chain strategies.

The Asia-Pacific region is characterized by rapid modernization of production systems, significant aquaculture activity, and evolving companion animal care markets. Growing investment in local manufacturing and R&D coexists with reliance on cross-border trade for specialized inputs. Regulatory reform, increasing regulatory capacity, and strong private sector participation are accelerating uptake of advanced biologics and molecular diagnostics. Across regions, companies must tailor commercial approaches to regulatory environments, channel structures, and the varying priorities of veterinarians, producers, and pet owners.

Strategic playbooks adopted by industry leaders focusing on innovation, supply chain resilience, and go-to-market modernization to maintain competitive advantage

Leading companies in the sector are adopting strategic postures that emphasize R&D intensity, portfolio diversification, and channel innovation. Firms are allocating resources toward novel vaccine platforms and molecular diagnostics while expanding capabilities in feed additives and biologics that address antimicrobial stewardship concerns. Strategic alliances between pharmaceutical developers and technology vendors enable faster integration of diagnostic-guided treatment pathways and digital health services.

Commercially, organizations are optimizing distribution through a mix of direct-to-clinic relationships and digital sales channels. Investments in cold-chain logistics and regional manufacturing capacities reduce exposure to supply disruptions and trade policy shifts. In parallel, some companies are pursuing selective M&A to acquire complementary technologies, strengthen presence in high-growth species segments, or secure access to regional markets.

Operational excellence remains a priority: advanced quality systems, regulatory affairs expertise, and scalable contract manufacturing relationships support faster product launches and lifecycle management. Companies that balance innovation with pragmatic supply chain and commercialization strategies will sustain competitiveness. Moreover, sustained engagement with veterinarians and producers-through training, technical support, and performance data-sharing-reinforces product value propositions and drives adoption.

Practical high-impact actions for company executives to strengthen resilience, accelerate digital adoption, and drive clinical and commercial outcomes in animal health

Leaders in animal health should take decisive, actionable steps to capture opportunity and mitigate risk across a dynamic landscape. First, prioritize flexible manufacturing and supplier diversification to reduce exposure to policy-driven disruptions and logistics volatility. This includes validating alternative sources for critical inputs, investing in regional fill-finish capacity for biologics, and negotiating contracts that allow pricing adjustments aligned with input cost fluctuations.

Second, accelerate digital transformation initiatives that connect diagnostics to care pathways and enable telemedicine and remote monitoring for both companion animals and livestock. Integrating diagnostic data with treatment protocols enhances clinical outcomes and supports value-based conversations with payers and producers. Third, invest in antimicrobial stewardship and alternative therapeutics, pairing these efforts with educational programs for veterinarians and producers to drive responsible use and meet regulatory expectations.

Fourth, tailor commercial models by region and end user, combining direct engagement with veterinarians, digital DTC experiences for pet owners, and strategic partnerships with feed manufacturers. Finally, embed sustainability and transparency into product lifecycles-ranging from raw material sourcing to packaging choices-to address customer and regulatory demands and to differentiate brands over the long term. Implementing these actions in a coordinated manner will strengthen resilience, accelerate adoption, and create measurable value across portfolios.

A transparent, multi-method research approach combining primary interviews, secondary evidence synthesis, and rigorous triangulation to underpin strategic findings

This research synthesizes qualitative and quantitative approaches to produce a rigorous, actionable analysis. Primary research included structured interviews with veterinarians, production managers, procurement professionals, and industry experts to capture frontline perspectives on clinical needs, purchasing drivers, and distribution challenges. Complementing this, secondary research drew on regulatory publications, scientific literature, patent filings, and publicly available company disclosures to map technological trajectories and competitive positioning.

Data triangulation techniques validated insights across sources, ensuring consistency between field feedback and documented trends. Segmentation analyses employed species, product modality, therapeutic application, distribution channel, and end-user lenses to surface differentiated opportunities and constraints. Regional assessments combined policy reviews with logistics and infrastructure analyses to determine how geography shapes adoption and supply chain design.

Analytical rigor was maintained through iterative hypothesis testing, peer review, and scenario analysis to stress-test assumptions related to trade policy impacts and technology adoption. Limitations include variability in regulatory timelines across jurisdictions and heterogeneous data quality in certain regional contexts; these were addressed by transparency in assumptions and by prioritizing primary stakeholder input where secondary data were sparse. Ethical considerations upheld confidentiality and voluntary participation for all interview subjects.

A concise synthesis of sector dynamics that highlights the interplay of innovation, regulation, and operational resilience driving future animal health strategies

In conclusion, the animal health sector is experiencing a fundamental reconfiguration driven by technological innovation, regulatory evolution, and shifting commercial models. Advances in diagnostics and vaccine platforms, the rise of digital health and precision livestock farming, and growing emphasis on antimicrobial stewardship collectively reshape product development and service delivery. Simultaneously, supply chain resilience and regional strategy have become central to sustaining access to essential therapeutics and preventive products.

Industry participants that align R&D priorities with stewardship goals, invest in flexible manufacturing and regional distribution, and deploy customer-centric digital offerings will be better positioned to capture long-term value. Equally important is proactive engagement with regulatory authorities and veterinary communities to ensure that new modalities achieve clinical acceptance and regulatory compliance. By synthesizing practical operational measures with strategic investment in innovation, organizations can navigate near-term policy disruptions while building durable competitive advantage.

Looking forward, continued collaboration across the public and private sectors, coupled with evidence-driven commercialization and responsible use practices, will be essential to advancing animal health outcomes, protecting public health, and supporting sustainable food systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of precision livestock farming technologies for real-time health monitoring in large dairy operations
• 5.2. Accelerated adoption of mRNA vaccine platforms to address emerging zoonotic threats in veterinary care
• 5.3. Implementation of artificial intelligence-driven decision support systems for optimized treatment protocols in companion animals
• 5.4. Expansion of antimicrobial stewardship programs in livestock production to combat rising antibiotic resistance
• 5.5. Increasing investment in microbiome modulation therapies as alternatives to traditional growth promoters in poultry
• 5.6. Advancements in telehealth and remote diagnostics for rural veterinary practice and livestock herd management
• 5.7. Emergence of blockchain-based supply chain traceability solutions to ensure transparency in animal product origin
• 5.8. Regulatory harmonization efforts to streamline global approval pathways for innovative animal health biologics
• 5.9. Growing focus on climate-adaptive nutrition strategies to improve animal resilience against environmental stressors
• 5.10. Development of species-specific monoclonal antibody therapies for preventive and therapeutic applications in livestock

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Health Market, by Animal Type

• 8.1. Companion Animals
  • 8.1.1. Cats
  • 8.1.2. Dogs
• 8.2. Livestock
  • 8.2.1. Aquaculture
  • 8.2.2. Cattle
  • 8.2.3. Poultry
  • 8.2.4. Swine

9. Animal Health Market, by Product

• 9.1. Diagnostics
  • 9.1.1. Immunological Diagnostics
  • 9.1.2. Molecular Diagnostics
• 9.2. Feed Additives
  • 9.2.1. Enzymes
  • 9.2.2. Prebiotics
  • 9.2.3. Probiotics
• 9.3. Parasiticides
  • 9.3.1. Ectoparasiticides
  • 9.3.2. Endoparasiticides
• 9.4. Pharmaceuticals
  • 9.4.1. Branded
  • 9.4.2. Generics
• 9.5. Vaccines
  • 9.5.1. Killed Inactivated
  • 9.5.2. Live Attenuated
  • 9.5.3. Recombinant

10. Animal Health Market, by Therapeutic Application

• 10.1. Anti Infectives
  • 10.1.1. Antibiotics
  • 10.1.2. Antifungals
  • 10.1.3. Antivirals
• 10.2. Anti Inflammatories
  • 10.2.1. Corticosteroids
  • 10.2.2. NSAIDs
• 10.3. Antiparasitics
  • 10.3.1. Ectoparasiticides
  • 10.3.2. Endoparasiticides
• 10.4. Hormonal Therapeutics
  • 10.4.1. Growth Hormones
  • 10.4.2. Reproductive Hormones

11. Animal Health Market, by Distribution Channel

• 11.1. Online Stores
  • 11.1.1. Direct To Consumer Websites
  • 11.1.2. Third Party Platforms
• 11.2. Retail Pharmacies
  • 11.2.1. Chain Pharmacies
  • 11.2.2. Independent Pharmacies
• 11.3. Veterinary Hospitals And Clinics
  • 11.3.1. Large Animal Hospitals
  • 11.3.2. Small Animal Clinics

12. Animal Health Market, by End User

• 12.1. Animal Owners
  • 12.1.1. Livestock Farmers
  • 12.1.2. Pet Owners
• 12.2. Feed Manufacturers
• 12.3. Veterinarians
  • 12.3.1. Large Animal Veterinarians
  • 12.3.2. Mixed Practice Veterinarians
  • 12.3.3. Small Animal Veterinarians

13. Animal Health Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Animal Health Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Animal Health Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Zoetis Inc.
  • 16.3.2. Merck & Co., Inc.
  • 16.3.3. Boehringer Ingelheim International GmbH
  • 16.3.4. Elanco Animal Health Incorporated
  • 16.3.5. IDEXX Laboratories, Inc.
  • 16.3.6. Ceva Sante Animale S.A.
  • 16.3.7. Vetoquinol S.A.
  • 16.3.8. Virbac S.A.
  • 16.3.9. Dechra Pharmaceuticals PLC
  • 16.3.10. Phibro Animal Health Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ANIMAL HEALTH MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ANIMAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ANIMAL HEALTH MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BRANDED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GENERICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL ANIMAL HEALTH MARKET SIZE, BY KILLED INACTIVATED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL ANIMAL HEALTH MARKET SIZE, BY NSAIDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ENDOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORMONAL THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL ANIMAL HEALTH MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 257. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 258. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 259. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 260. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REPRODUCTIVE HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 261. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 262. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 263. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
• TABLE 264. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, 2025-2032 (USD MILLION)
• TABLE 265. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 266. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 267. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 268. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 269. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 272. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 273. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 274. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 275. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 276. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIRECT TO CONSUMER WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 277. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 278. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 279. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 280. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 281. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 282. GLOBAL ANIMAL HEALTH MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 283. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
• TABLE 284. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
• TABLE 285. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 286. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 287. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 288. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 289. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 290. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 291. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 292. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 293. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 294. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 295. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 296. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 297. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 298. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 299. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 300. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 301. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 302. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 303. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
• TABLE 304. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
• TABLE 305. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 306. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 307. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 308. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 309. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 310. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 311. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 312. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 313. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 314. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 315. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 316. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 317. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 318. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 319. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 320. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 321. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 322. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SMALL ANIMAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 323. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 324. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 325. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2018-2024 (USD MILLION)
• TABLE 326. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, 2025-2032 (USD MILLION)
• TABLE 327. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 328. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 329. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 330. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 331. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 332. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 333. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 334. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 335. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 336. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 337. GLOBAL ANIMAL HEALTH MARKET SIZE, BY LIVESTOCK FARMERS,